Testimonials
  • Natasha F., Ga.

    I received a call within 5 minutes of submitting my request! I was amazed at the prompt response!
  • Ann M., Penn.

    The service was great, prompt response. Thank you!
  • Joseph E., Al.

    I received a call within 5 minutes of submitting my request! I was amazed at the prompt response! The service was great, prompt response. Thank you! I am telling others how much easier it is than to go through a phone book and look at ads.
  • Debra S., Ca.

    I am telling others how much easier it is than to go through a phone book and look at ads.
  • Bob M., Ky.

    I think your service is great! Without your help I would not have been able to find an attorney knowledgeable for my needs.
  • Ann M., Penn.

    The service was great, prompt response. Thank you!
  • Aisha B., Md

    The attorney that responded was very professional, resourceful, helpful and courteous to me in regards to my situation. Thank you.


About Crestor

As reported by the consumer group Public Citizen, AstraZeneca originally filed its application with the FDA to market rosuvastatin in June 2001. The application was delayed after reports of kidney damage and muscle weakness (an early signal for rhabdomyolysis) in clinical trials in patients taking 80 milligrams of the drug per day. The company stopped development of the 80 milligram dose, and rosuvastatin will only be sold in 5, 10, 20, and 40 milligram strengths. There will also be special restrictions on the distribution of the 40 milligram strength.

Public Citizen opposed the approval of rosuvastatin because it alleged that the drug causes abnormal elevations in urine protein and blood that are signals for serious kidney toxicity, and is the only statin that has shown life-threatening rhabdomyolysis in pre-approval clinical trials.

Rhabdomyolysis is a potentially life-threatening condition that occurs when a large number of skeletal muscle cells die, resulting in the release of a massive amount of muscle protein (known as myogloblin) into the bloodstream. The muscle protein can become trapped in the kidneys, clogging up the filtering process of the kidneys and leading to kidney or renal failure. In addition, potassium released from the damaged muscle cells can cause malignant heart rhythms resulting in cardiac arrest.

 

Privacy Policy | Disclaimer


Copyright Calliope Media, Inc. © 2011 --- All Rights Reserved.




First Name:
Last Name:
Address:
Zipcode:
City:
Primary Phone:
Email:

Were you or a loved one prescribed Crestor®?



Did you or a loved one suffer any of the following while using Crestor®?

Do you currently have a lawyer representing your Crestor® case?



Tell us about your case.




By leaving this box checked, I agree that submission does not establish an attorney client relationship and may be reviewed by one or more law firms.  I agree to receive future announcements from our firm and partners.

Please fix these first